The safety and immunogenicity of a human immunodeficiency virus type 1 (HIV-1) recombinant gp160 candidate vaccine in humans. NIAID AIDS Vaccine Clinical Trials Network.

Source:http://linkedlifedata.com/resource/pubmed/id/1984386

Ann. Intern. Med. 1991 Jan 15 114 2 119-27

Download in:

View as

Triples

General Info

PMID
1984386